ELOA Gene: Elongin A Subunit of RNA Polymerase II Transcription Elongation Factor

Comprehensive gene card for ELOA (TCEB3) – function, expression, mutations, and disease associations

Gene Information Card

Symbol ELOA
Full Name elongin A
Gene Type protein-coding
Chromosomal Location 1p36.11
NCBI Gene ID 6924 ncbi.nlm.nih.gov/gene/6924
Ensembl ID ENSG00000117461
UniProt ID Q14241
OMIM ID 600786
HGNC ID 11619
Aliases TCEB3, SIII, Elongin A

Description

ELOA (elongin A) encodes the A subunit of the elongin complex, which stimulates RNA polymerase II transcription elongation by suppressing transient pausing. The elongin complex consists of elongin A, B, and C. Elongin A functions as the transcriptionally active subunit, while elongin B and C are regulatory. ELOA is involved in cellular stress responses and has been implicated in cancer and developmental disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Neurodevelopmental disorder with hypotonia and brain abnormalities Biallelic loss-of-function mutations in ELOA impair transcription elongation, leading to neuronal dysfunction ClinVar, OMIM
Colorectal cancer Somatic mutations and altered expression of ELOA may contribute to tumor progression COSMIC, NCBI
Breast cancer Overexpression of ELOA associated with poor prognosis; potential role in transcriptional dysregulation COSMIC, NCBI

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.5 Medium
Brain 8.3 Low
Heart 6.1 Low
Liver 4.7 Low
Kidney 5.9 Low
Cell Line Expression
Cell Line nTPM Notes
HEK 293 10.2 Embryonic kidney cells
HeLa 8.9 Cervical cancer cells
K562 7.4 Leukemia cells
HepG2 6.8 Liver cancer cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense Rare Loss of start codon; likely loss of function
c.325C>T (p.Arg109*) Nonsense Rare Premature stop; loss of function
c.502G>A (p.Gly168Arg) Missense Rare Unknown significance; possibly damaging
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations in ELOA lead to truncated or absent protein, impairing transcription elongation.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in ELOA.

Dominant Negative (DN)

Missense mutations in the elongin A domain may disrupt complex assembly, potentially acting in a dominant-negative manner.

Pathways

RNA polymerase II transcription elongation (Reactome: R-HSA-75955)
Elongin complex assembly (Reactome: R-HSA-8951936)

Protein Summary

Elongin A (ELOA) is a 772-amino acid protein that contains a von Willebrand factor type A (vWA) domain and a C-terminal domain essential for interaction with elongin B/C. It directly binds RNA polymerase II and stimulates elongation by reducing pausing. Post-translational modifications include phosphorylation and ubiquitination, which regulate its stability and activity.

Related Products

Product name Cat.No. Species Gene ID
ELOA Knockout HEK293 Cell Line EDJ-KQ5900 Human 6924 Details Get a Quote
ELOA2 Knockout HEK293 Cell Line EDJ-KQ10980 Human 51224 Details Get a Quote
ELOA Knockout A-549 Cell Line EDJ-KQ29413 Human 6924 Details Get a Quote
ELOA Knockout HCT 116 Cell Line EDJ-KQ29414 Human 6924 Details Get a Quote
ELOA Knockout HeLa Cell Line EDJ-KQ29415 Human 6924 Details Get a Quote
ELOA2 Knockout HeLa Cell Line EDJ-KQ56254 Human 51224 Details Get a Quote
ELOA2 Knockout A-549 Cell Line EDJ-KQ64743 Human 51224 Details Get a Quote
ELOA2 Knockout HCT 116 Cell Line EDJ-KQ73188 Human 51224 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: